A Role for EZH2 in Silencing of IFN-γ Inducible MHC2TA Transcription in Uveal Melanoma1

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Immunology

• Publication date

  2007-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.179.8.5317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer

  2007cited by this paper
• The Polycomb group protein EZH2 directly controls DNA methylation

  2007influential reference
• Genomic DNA methylation: the mark and its mediators.

  2006cited by this paper
• Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.

  2005cited by this paper
• T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-gamma promoter via a conserved T-box half-site.

  2005cited by this paper
• Chromatin modifier enzymes, the histone code and cancer.

  2005cited by this paper
• Histone Deacetylases as Transcriptional Activators? Role Reversal in Inducible Gene Regulation

  2005cited by this paper
• Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors.

  2005cited by this paper
• Intergenic Transcription Is Not Required in Th2 Cells to Maintain Histone Acetylation and Transcriptional Permissiveness at the Il4-Il13 Locus1

  2005cited by this paper
• Relationship between Histone H3 Lysine 9 Methylation, Transcription Repression, and Heterochromatin Protein 1 Recruitment

  2005cited by this paper
• The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

  2004cited by this paper
• Transcriptional regulation of antigen presentation.

  2004cited by this paper
• Interferon-gamma induces caspase-8 in neuroblastomas without affecting methylation of caspase-8 promoter.

  2004cited by this paper
• Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-γ-induced HLA-DR expression in colorectal and gastric cancer cells

  2004cited by this paper
• Regulation of MHC class II expression in human T-cell malignancies.

  2004cited by this paper
• Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells

  2004cited by this paper
• Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.

  2004cited by this paper
• Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.

  2004cited by this paper
• DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies.

  2003cited by this paper
• The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase.

  2003influential reference
• Class II Transactivator (CIITA) Promoter Methylation Does Not Correlate with Silencing of CIITA Transcription in Trophoblasts1

  2003cited by this paper
• Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains.

  2003cited by this paper
• Histone Deacetylation, But Not Hypermethylation, Modifies Class II Transactivator and MHC Class II Gene Expression in Squamous Cell Carcinomas1

  2003cited by this paper
• Regulation of human β2-microglobulin transactivation in hematopoietic cells

  2003cited by this paper
• Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

  2002cited by this paper
• Kinetics of a Gamma Interferon Response: Expression and Assembly of CIITA Promoter IV and Inhibition by Methylation

  2002influential reference
• Lack of ifn‐γ‐mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines

  2002cited by this paper
• HLA expression in uveal melanoma: there is no rule without some exception.

  2002cited by this paper
• DNA Alkylating Agents Alleviate Silencing of Class II Transactivator Gene Expression in L1210 Lymphoma Cells1

  2002cited by this paper
• Association of HLA class I and class II antigen expression and mortality in uveal melanoma.

  2001cited by this paper
• SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3*

  2001cited by this paper
• Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.

  2000cited by this paper
• Activation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors1

  2000cited by this paper
• Methylation of Class II trans-Activator Promoter IV: A Novel Mechanism of MHC Class II Gene Control1

  2000cited by this paper
• Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene

  2000cited by this paper
• The correlation between cell surface markers and clinical features in choroidal malignant melanomas

  1999cited by this paper
• Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1.

  1998cited by this paper
• Site α Is Crucial for Two Routes of IFNγ-Induced MHC Class I Transactivation: The ISRE-Mediated Route and a Novel Pathway Involving CIITA

  1997cited by this paper
• HLA antigen expression on uveal melanoma cells in vivo and in vitro.

  1995cited by this paper
• A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.

  1992cited by this paper
• Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.

  1990cited by this paper
• Epidemiologic aspects of uveal melanoma.

  1988cited by this paper

• Biological characteristics and clinical management of uveal and conjunctival melanoma

  2024cites this paper
• Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines – A Pilot Study

  2024cites this paper
• Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota

  2023cites this paper
• EHMT2 promotes tumorigenesis in GNAQ/11-mutant uveal melanoma via ARHGAP29-mediated RhoA pathway

  2023cites this paper
• Epigenetic drug library screening reveals targeting DOT1L abrogates NAD+ synthesis by reprogramming H3K79 methylation in uveal melanoma

  2022cites this paper
• Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma.

  2021cites this paper
• HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma

  2020cites this paper
• Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker

  2020cites this paper
• Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition.

  2020cites this paper
• Uveal melanoma: progress in molecular biology and therapeutics

  2020cites this paper
• HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target

  2019cites this paper
• Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.

  2018cites this paper
• Epigenetic mechanisms of tumor resistance to immunotherapy

  2018cites this paper
• Biological Consequences of MHC-II Expression by Tumor Cells in Cancer

  2018cites this paper
• Genetic and epigenetic insights into uveal melanoma

  2018cites this paper
• IFN-γ Induces Histone 3 Lysine 27 Trimethylation in a Small Subset of Promoters to Stably Silence Gene Expression in Human Macrophages.

  2016cites this paper
• Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes

  2016cites this paper
• Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma

  2016cites this paper
• PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma

  2016cites this paper
• Role of EZH2 histone methyltrasferase in melanoma progression and metastasis

  2016cites this paper
• Polycomb Repressive Complex 2 Confers BRG1 Dependency on the CIITA Locus

  2015cites this paper
• The variant rs8048002 T>C in intron 3 of the MHC2TA gene is associated with risk of developing acute coronary syndrome.

  2015cites this paper
• Cancer Cells Hijack PRC2 to Modify Multiple Cytokine Pathways

  2015cites this paper
• Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy

  2015cites this paper
• Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes

  2015cites this paper
• EZH2: an emerging role in melanoma biology and strategies for targeted therapy

  2015cites this paper
• Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

  2015cites this paper
• STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin?

  2013cites this paper
• Histone deacetylase inhibitors suppress immune activation in primary mouse microglia

  2013cites this paper
• The MHC2TA 1614 C>G gene polymorphism is associated with risk of developing acute coronary syndrome.

  2013cites this paper
• Exploiting tumor epigenetics to improve oncolytic virotherapy

  2013cites this paper
• ZBTB32 Is an Early Repressor of the CIITA and MHC Class II Gene Expression during B Cell Differentiation to Plasma Cells

  2012cites this paper
• Dysregulated Recruitment of the Histone Methyltransferase EZH2 to the Class II Transactivator (CIITA) Promoter IV in Breast Cancer Cells

  2012cites this paper
• Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors

  2012cites this paper
• The MHC2TA gene polymorphisms are not associated with restenosis after coronary stenting in Mexican patients.

  2012cites this paper
• CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells

  2012cites this paper
• The 26S Proteasome and Histone Modifying Enzymes Regulate

  2011cites this paper
• Early epigenetic events regulate the adaptive immune response gene CIITA

  2011cites this paper
• Epigenetic regulation of CIITA expression in human T-cells.

  2011cites this paper
• Epigenetic control in immune function.

  2011cites this paper
• Expression Regulation of Major Histocompatibility Complex Class I and Class II Encoding Genes

  2011cites this paper
• Influence of Immune Privilege on Ocular Tumor Development

  2010cites this paper
• PU.1 Binds to a Distal Regulatory Element That Is Necessary for B Cell-Specific Expression of CIITA

  2010cites this paper
• Polycomb Target Genes Are Silenced in Multiple Myeloma

  2010cites this paper
• Dynamic patterns of histone lysine methylation in the developing retina.

  2010cites this paper
• Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes

  2010cites this paper
• Genetic and Epigenetic Control of the Major Histocompatibility Complex Class Ib Gene HLA‐G in Trophoblast Cell Lines

  2009cites this paper
• Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling.

  2008cites this paper
• CC chemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor.

  2008cites this paper